|Bid||1.13 x 100|
|Ask||5.50 x 10000|
|Day's Range||4.34 - 4.52|
|52 Week Range||2.91 - 12.24|
|PE Ratio (TTM)||-1.89|
|Earnings Date||Oct 30, 2017 - Nov 3, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||6.13|
REDWOOD CITY, Calif., Sept. 19, 2017-- OncoMed Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced that ...
REDWOOD CITY, Calif., Sept. 13, 2017-- OncoMed Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, announced today that ...
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to OncoMed Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to OMED-US. Comparing the performance and risk of OncoMed Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)